Skip to main content
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published loading...Updated

Azelastine Nasal Spray Reduces Risk of Sars-Cov-2 Infections

Munich — A nasal spray containing 0.1% azelastine may reduce the risk of SARS-CoV-2 infections. It may also be effective against other respiratory viruses, reported Thorsten Lehr from Saarland University in Homburg at this year's congress of the German Society of Pneumology and Respiratory Medicine in Munich (DGP)...
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

Munich — A nasal spray containing 0.1% azelastine may reduce the risk of SARS-CoV-2 infections. It may also be effective against other respiratory viruses, reported Thorsten Lehr from Saarland University in Homburg at this year's congress of the German Society of Pneumology and Respiratory Medicine in Munich (DGP)...

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Deutsches Ärzteblatt broke the news in on Wednesday, April 1, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal